Mylan Accused by Sanofi of Trying to `Squelch' EpiPen Rival

Bookmark
(Bloomberg) -- Mylan NV engaged in a campaign to squash a rival to its EpiPen allergy treatment and artificially inflate the price of the drug to maintain a market monopoly, French drugmaker Sanofi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.